Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000

被引:7
作者
Braitstein, P
Yip, B
Heath, KV
Levy, AR
Montaner, JSG
Humphries, K
Kiely, FM
O'Shaughnessy, MV
Hogg, RS
机构
[1] BC Ctr Excellence HIV AIDS, Div Epidemiol & Publ Hlth, Vancouver, BC V6Z 1Y6, Canada
[2] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
[3] St Pauls Hosp, British Columbia Cardiac Registries, Vancouver, BC V5Z 1M9, Canada
[4] Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada
[6] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
关键词
cardiovascular disease; antiretroviral drugs; adverse effects; HIV; Canada;
D O I
10.1097/00002030-200309260-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To calculate the rate of interventional cardiac procedures (ICP) among HIV-infected individuals ever treated with antiretroviral therapy (ART) and to describe clinical and sociodemographic characteristics associated with ICP. Methods: Since 1992, ART in British Columbia (BC) has been centrally distributed by the BC Centre for Excellence in HIV/AIDS. The BC Cardiac Registry maintains information regarding all cardiac procedures performed in BC. The two databases were linked to determine the number of HIV-positive individuals on ART who underwent ICP. Age-adjusted analyses were conducted using direct standardization, and linear regression to test for trend over time. Logistic regression was used to identify patient and treatment characteristics independently associated with having an interventional cardiac procedure. Results: Of the 5082 individuals who have ever received ART, 63 (< 1 %) were captured in the Cardiac Registry. There were 97 events: 70 (72%) since 1999. The age-adjusted event rate per 1000 HIV-positive individuals on ART increased significantly over time (P= 0.015) whereas that for the general BC population did not increase over time (P=0.191). In multivariate analysis, age at baseline per 10 year increase [adjusted odds ratio (AOR) 2.5; 95% confidence interval (Cl), 1.8-3.2), and months on ART (AOR 1.3; 95% Cl, 1.1 - 1.4) remained significant. Conclusions: The rate of ICP among HIV-positive individuals on ART appears to be increasing; in addition, the duration of time on ART is independently associated with ICP after adjustment for patient demographic characteristics. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:2071 / 2075
页数:5
相关论文
共 19 条
[1]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390
[2]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[3]   Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154
[4]   Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review [J].
Duong, M ;
Buisson, M ;
Cottin, Y ;
Piroth, L ;
Lhuillier, I ;
Grappin, M ;
Chavanet, P ;
Wolff, JE ;
Portier, H .
CLINICAL CARDIOLOGY, 2001, 24 (10) :690-694
[5]  
*GOV BRIT COL, 2001, BC STAT 2001 VICT BC
[6]   Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy [J].
Hadigan, C ;
Meigs, JB ;
Corcoran, C ;
Rietschel, P ;
Piecuch, S ;
Basgoz, N ;
Davis, B ;
Sax, P ;
Stanley, T ;
Wilson, PWF ;
D'Agostino, RB ;
Grinspoon, S .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :130-139
[7]  
HENRY K, 2001, 8 C RETR OPP INF CHI
[8]   Decline in deaths from AIDS due to new antiretrovirals [J].
Hogg, RS ;
OShaughnessy, MV ;
Gataric, N ;
Yip, B ;
Craib, K ;
Schechter, MT ;
Montaner, JSG .
LANCET, 1997, 349 (9061) :1294-1294
[9]  
Hogg RS, 1999, CAN MED ASSOC J, V160, P659
[10]  
HOGG RS, 2002, AIDS 2002, V16, P2065